References
Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, Tiftik EN (2017) Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases. Indian J Hematol Blood Transfus 33:97–105
Rock G, Clark B, Sutton D, CAG, CAAN (2003) The Canadian apheresis registry. Transfus Apher Sci 29:167–177
Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for apheresis: the seventh special issue. J Clin Apher 31:149–162
Hartog CS, Natanson C, Sun J, Klein HG, Reinhart K (2014) Concerns over use of hydroxyethyl starch solutions. BMJ 349:g5981
Howell C, Douglas K, Cho G, El-Ghariani K, Taylor P, Potok D, Rintala T, Watkins S (2015) Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British committee for standards in haematology. Transfus Med 25:57–78
Brecher ME, Owen HG (1996) Washout kinetics of colloidal starch as a partial or full replacement for plasma exchange. J Clin Apher 11:123–126
Auwerda JJ, Leebeek FW, Wilson JH, van Diggelen OP, Lam KH, Sonneveld P (2014) Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 46:1705–1711
Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40:160–170
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
CJW has received fees for speaking and travel cost reimbursements from CSL Behring, Grifols, Baxter and Kedrion. AP and GG have no conflict of interest to declare.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Wiedermann, C.J., Piccin, A. & Gulli, G. Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Insufficient Evidence to Support the Use of Hydroxyethyl Starch. Indian J Hematol Blood Transfus 33, 445–447 (2017). https://doi.org/10.1007/s12288-017-0833-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-017-0833-9